Anticancer Activity of Bee Venom Components against Breast Cancer

Toxins (Basel). 2022 Jul 5;14(7):460. doi: 10.3390/toxins14070460.

Abstract

While the survival rate has increased due to treatments for breast cancer, the quality of life has decreased because of the side effects of chemotherapy. Various toxins are being developed as alternative breast cancer treatments, and bee venom is drawing attention as one of them. We analyzed the effect of bee venom and its components on breast cancer cells and reviewed the mechanism underlying the anticancer effects of bee venom. Data up to March 2022 were searched from PubMed, EMBASE, OASIS, KISS, and Science Direct online databases, and studies that met the inclusion criteria were reviewed. Among 612 studies, 11 were selected for this research. Diverse drugs were administered, including crude bee venom, melittin, phospholipase A2, and their complexes. All drugs reduced the number of breast cancer cells in proportion to the dose and time. The mechanisms of anticancer effects included cytotoxicity, apoptosis, cell targeting, gene expression regulation, and cell lysis. Summarily, bee venom and its components exert anticancer effects on human breast cancer cells. Depending on the mechanisms of anticancer effects, side effects are expected to be reduced by using various vehicles. Bee venom and its components have the potential to prevent and treat breast cancer in the future.

Keywords: bee venom; breast cancer; melittin; phospholipase A2.

Publication types

  • Review

MeSH terms

  • Apoptosis
  • Bee Venoms* / therapeutic use
  • Bee Venoms* / toxicity
  • Breast Neoplasms* / drug therapy
  • Female
  • Humans
  • Melitten / pharmacology
  • Melitten / therapeutic use
  • Quality of Life

Substances

  • Bee Venoms
  • Melitten

Grants and funding

This research received no external funding.